Differences in outcome for cervical cancer patients treated with or without brachytherapy

J Karlsson, AC Dreifaldt, LB Mordhorst, B Sorbe - Brachytherapy, 2017 - Elsevier
Purpose To compare the clinical outcome of cervical cancer patients treated with primary
radiotherapy with and without the addition of brachytherapy. Methods and Materials In all, 220 …

[HTML][HTML] Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily …

M Kaliff, B Sorbe, LB Mordhorst, G Helenius… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Cervical cancer (CC) is one of the most common cancers in women and virtually all cases of
CC are a result of a persistent infection of human papillomavirus (HPV). For disease …

[HTML][HTML] HPV-negative tumors in a Swedish cohort of cervical cancer

…, MG Karlsson, B Sorbe, LB Mordhorst… - International Journal …, 2020 - journals.lww.com
Despite the common perception that the human papilloma virus (HPV) is a requirement for
the development of cervical cancer (CC), a considerable number of CCs test HPV negative. …

[HTML][HTML] Optimization of droplet digital PCR assays for the type-specific detection and quantification of five HPV genotypes, including additional data on viral loads of …

K Malin, BM Louise, H Gisela, KG Mats… - Journal of Virological …, 2021 - Elsevier
The droplet digital PCR (ddPCR) system enables high-sensitivity detection of nucleic acids
and direct absolute quantification of the targets. The aim of this research was to evaluate this …

Combined external pelvic chemoradiotherapy and image-guided adaptive brachytherapy in treatment of advanced cervical carcinoma: experience from a single …

S Möller, LB Mordhorst, R Hermansson… - Journal of …, 2020 - termedia.pl
Purpose Cervical cancer ranges as the fourth most frequently diagnosed cancer and the
fourth leading cause of death among women worldwide as presented by the International …

3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and …

L Karlsson, P Thunberg, LB Mordhorst… - Journal of …, 2017 - termedia.pl
Purpose: Using 3D image-guided adaptive brachytherapy for cervical cancer treatment, it
often means that patients are transported and moved during the treatment procedure. The …

Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation …

LB Mordhorst, L Karlsson, B Bärmark… - International Journal of …, 2014 - ijgc.bmj.com
Objective The objective of this study was to find out predictive factors of tumor control as
well as acute and late radiation reactions in treatment of advanced cervical carcinomas. …

Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I–IV treated with radiotherapy or chemoradiotherapy

LB Mordhorst, C Ahlin, B Sorbe - Gynecologic oncology, 2014 - Elsevier
Objective Hedgehog signaling proteins were assessed in patients with cervical carcinoma
receiving chemoradiation. Associations between five Hedgehog proteins and prognosis were …

A study of serum biomarkers associated with relapse of cervical cancer

LB Mordhorst, B Sorbe, C Ahlin - Anticancer research, 2012 - ar.iiarjournals.org
Background/Aim: To discover candidate protein biomarkers in the serum of patients with
cervical cancer that differentiate between patients with relapse from those who are tumor-free …

[HTML][HTML] Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy

LB Mordhorst, C Ahlin, B Sorbe - Oncotarget, 2016 - ncbi.nlm.nih.gov
Wnt signaling proteins were assessed in patients with primary cervical carcinomas who
received chemoradiation. The associations between three Wnt signaling proteins and prognosis …